Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Neuraly. Among the most successful fund investment fields, there are Health Care, Biotechnology.
The top activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 9 partakers. The meaningful sponsors for the fund in investment in the same round are Smilegate Investment, Octave Life Sciences, Maryland Venture Fund.
Related Funds
| Fund Name | Location |
| BBVA | Panamá, Panama, Panama City |
| Beijing Yuzhou Zhixin Jiaoyu Keji | Beijing, Beijing, China |
| Deutsche Invest Equity Partners GmbH | Bayern, Germany, Munich |
| DW Fund | China, Shanghai, Xuhui |
| Epicenter Logistics Innovation Accelerator | Memphis, Tennessee, United States |
| FRH Group | Eastleigh, England, United Kingdom |
| Granite Point Capital | Boston, Massachusetts, United States |
| Informix | Armonk, New York, United States |
| Larsen MacColl Partners | Pennsylvania, Radnor, United States |
| Luxembourgian ACME Investments | - |
| Manitoba | Canada, Manitoba, Winnipeg |
| Oita Bank | Japan, Oita, Oita Prefecture |
| Ontario Ministry of Economic Development | Canada, Ontario, Toronto |
| SF Investments | - |
| Shengshan Asset Management | China, Hangzhou, Zhejiang |
| The Hartford | Connecticut, Hartford, United States |
| Tsunagu Solutions | Japan, Tokyo |
| UNIIQ | Den Haag, The Netherlands, Zuid-Holland |
| Wanshi Capital | - |
| Whitewater Bancorp | United States, Whitewater, Wisconsin |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Valted Seq | $10M | 02 Nov 2021 | Gaithersburg, Maryland, United States | ||
My Chef | 14 May 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Neuraly | $36M | 18 Jul 2018 | Maryland, United States | ||
D&D Pharmatech | $36M | 01 Jan 2018 | Seongnam-si |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Valted Seq | $10M | 02 Nov 2021 | Gaithersburg, Maryland, United States | ||
My Chef | 14 May 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Neuraly | $36M | 18 Jul 2018 | Maryland, United States | ||
D&D Pharmatech | $36M | 01 Jan 2018 | Seongnam-si |
